object
present
studi
evalu
protect
effect
humor
cellular
immun
turkey
infect
turkey
coronaviru
tcv
two
trial
conduct
two
separ
hatch
turkey
poult
turkey
experiment
immunosuppress
cyclosporin
csa
cyclophosphamid
cy
infect
tcv
prior
infect
treatment
csa
select
suppress
cell
activ
reveal
fold
decreas
p
lymphocyt
prolifer
respons
cell
mitogen
concanavalin
con
treatment
cy
mainli
induc
b
cell
indic
reduct
p
antibodi
respons
sheep
erythrocyt
day
inject
bodi
weight
gain
turkey
treat
cy
lower
p
untreat
turkey
day
postinfect
pi
turkey
treat
cy
fold
higher
antibodi
assay
ifa
score
tcv
antigen
p
intestin
untreat
turkey
day
pi
result
suggest
humor
immun
tcv
infect
may
import
turkey
q
turkey
coronavir
enter
acut
highli
infecti
diseas
contribut
econom
loss
us
turkey
industri
particularli
indiana
north
carolina
last
decad
clinic
sign
diarrhea
decreas
bodi
weight
gain
inappet
feather
diseas
usual
appear
turkey
poult
day
age
morbid
usual
high
mortal
vari
epidemiolog
studi
turkey
coronaviru
tcv
poult
enter
mortal
syndrom
pem
north
carolina
guy
barn
unpublish
data
coronaviru
isol
affect
found
antigen
crossreact
antibodi
infecti
bronchiti
viru
ibv
chicken
coronaviru
coronavir
enter
introduc
area
high
concentr
turkey
easili
elimin
encount
frequent
treatment
diseas
often
unsuccess
current
effect
vaccin
medic
prevent
viral
infect
like
diseas
continu
neg
impact
turkey
industri
effect
strategi
prevent
control
diseas
establish
infect
host
anim
coronavirus
bovin
coronaviru
bcv
transmiss
gastroenter
viru
tgev
ibv
stimul
protect
anim
subsequ
challeng
viru
although
detail
mechan
protect
clear
protect
immun
induc
correspond
coronaviru
primari
infect
essenti
serum
igg
fecal
iga
antibodi
respons
increas
follow
secondari
exposur
bcv
virusneutr
antibodi
respons
serum
also
increas
follow
secondari
challeng
bcv
presenc
high
number
antibodysecret
cell
high
lymphocyt
prolifer
activ
correl
protect
subsequ
challeng
tgev
antibodi
respons
ibv
detect
serum
tracheal
wash
tear
chicken
infect
ibv
vaccin
studi
ibv
gener
correl
neutral
serum
antibodi
respons
protect
recov
coronavir
enter
bluecomb
diseas
may
develop
lifelong
immun
challeng
infect
howev
natur
resist
complet
understood
serum
recov
turkey
could
neutral
infect
tcvcontain
intestin
content
serum
antibodi
tcv
detect
antibodi
assay
ifa
day
postinfect
pi
antibodi
tcv
intestin
bile
detect
immunodiffus
test
sandwich
ifa
month
pi
lymphocyt
prolifer
respons
mitogen
report
enhanc
turkey
infect
tcv
addit
sequenti
kinet
studi
humor
cellular
immun
respons
turkey
poult
infect
tcv
isol
laboratori
shown
activ
immun
respons
humor
cellular
associ
decreas
tcv
antigen
turkey
intestin
unpublish
data
howev
immun
humor
cellular
provid
necessari
protect
immun
turkey
poult
infect
tcv
clear
inform
critic
develop
strategi
diagnosi
control
prevent
turkey
coronavir
infect
purpos
present
studi
determin
protect
immun
turkey
coronavir
infect
turkey
infect
tcv
turkey
poult
treat
select
cell
immunosuppress
cyclosporin
csa
b
cell
immunosuppress
cyclophosphamid
cy
subsequ
challeng
tcv
sever
infect
evalu
compar
onedayold
turkey
poult
british
unit
turkey
american
buta
sex
obtain
perdu
farm
washington
free
recogn
pathogen
turkey
includ
tcv
hous
isol
unit
negativepressur
ventil
food
water
provid
ad
libitum
tcv
isol
intestin
turkey
poult
outbreak
acut
enter
affect
intestin
homogen
volum
phosphatebuff
salin
pb
solut
centrifug
g
min
mm
membran
millipor
bedford
twentytwo
dayold
embryon
turkey
egg
inocul
ml
via
amniot
sac
rout
embryo
intestin
harvest
day
intestin
serial
propag
tcvinfect
turkey
embryo
homogen
volum
pb
buffer
mixtur
centrifug
g
min
supernat
use
inoculum
experiment
infect
turkey
poult
inoculum
examin
electron
microscopi
em
immunoem
contain
tcv
pathogen
two
trial
two
separ
hatch
turkey
poult
conduct
experiment
design
trial
outlin
tabl
trial
turkey
poult
randomli
separ
four
group
thirti
turkey
poult
group
treat
csa
day
old
everi
third
day
thereaft
thirti
turkey
poult
group
ii
treat
cy
day
old
thirti
turkey
poult
group
iii
treat
immunosuppress
day
old
turkey
poult
group
use
evalu
humor
antibodi
respons
sheep
red
blood
cell
srbc
anoth
turkey
poult
group
use
evalu
cellular
immunocompet
vitro
lymphocyt
prolifer
assay
remain
turkey
poult
group
infect
tcv
day
old
twenti
turkey
poult
group
iv
neither
treat
immunosuppress
infect
tcv
serv
normal
control
group
five
poult
four
group
weight
day
age
prior
infect
poult
weight
day
age
termin
experi
bodi
weight
gain
individu
poult
calcul
five
poult
randomli
select
group
necropsi
h
day
pi
intestin
collect
bird
durat
tcv
intestin
examin
ifa
trial
turkey
poult
randomli
separ
three
group
turkey
poult
group
treat
csa
day
old
everi
third
day
thereaft
turkey
poult
group
ii
treat
cy
day
old
turkey
poult
group
iii
treat
immunosuppress
day
old
turkey
poult
group
use
evalu
humor
antibodi
respons
srbc
anoth
turkey
poult
group
use
evalu
cellular
immunocompet
vitro
lymphocyt
prolifer
assay
remain
tabl
experiment
design
treatment
trial
day
age
day
pi
h
x
x
turkey
poult
treat
csa
mg
per
kg
bodi
weight
everi
third
day
indic
b
turkey
poult
treat
cy
mg
per
turkey
poult
per
day
day
posthatch
c
turkey
poult
intramuscularli
inject
srbc
day
age
antibodi
titer
srbc
determin
hemagglutin
day
inject
lymphocyt
prolifer
respons
con
e
turkey
poult
infect
tcv
day
age
f
bodi
weight
bw
gain
determin
prior
infect
day
age
g
ifa
tcv
antigen
intestin
turkey
poult
group
infect
tcv
day
old
five
poult
four
group
weight
day
age
prior
infect
poult
weight
day
age
termin
experi
bodi
weight
gain
individu
poult
calcul
five
poult
randomli
select
group
necropsi
day
pi
intestin
collect
bird
durat
tcv
intestin
examin
ifa
csa
biomol
plymouth
meet
pa
dissolv
miner
oil
administ
intramuscularli
everi
day
previous
describ
dose
mg
per
kg
bodi
weight
turkey
poult
given
dose
day
old
day
prior
challeng
infect
trial
day
old
day
prior
challeng
infect
trial
receiv
subsequ
dose
everi
third
day
thereaft
throughout
experiment
period
cy
sigma
st
loui
mo
administ
intraperiton
daili
dose
mg
per
turkey
poult
day
posthatch
previous
describ
tendayold
turkey
poult
group
treat
csa
cy
untreat
group
inject
intraven
ml
salin
suspens
srbc
sigma
prior
infect
tcv
blood
sampl
collect
day
inject
antisrbc
antibodi
titer
hemagglutin
assay
titer
express
log
reciproc
highest
dilut
visibl
agglutin
observ
blood
obtain
turkey
poult
group
treat
csa
cy
untreat
group
prior
infect
tcv
heparin
blood
dilut
dispens
plate
well
three
sequenti
triplic
cultur
ad
ml
rpmi
medium
without
mitogen
contain
mgml
concanavalin
con
sigma
cell
cultur
incub
h
humidifi
air
atmospher
co
cultur
puls
mci
hthymidin
ml
rpmi
medium
per
well
h
incub
cell
harvest
onto
glass
paper
automat
cell
harvest
packard
downer
grove
il
count
per
minut
cpm
valu
individu
cell
sampl
measur
packard
topcount
scintil
counter
model
packard
cpm
valu
triplic
cultur
within
sampl
averag
stimul
index
si
calcul
divid
averag
cpm
valu
mitogenstimul
cultur
averag
cpm
valu
unstimul
cultur
jejunum
ileum
distal
merckel
diverticulum
turkey
poult
time
interv
obtain
ifa
ifa
use
detect
tcv
describ
previous
intestin
frozen
immedi
embed
tissuetek
oct
compound
mile
laboratori
elkhart
intestin
section
cut
serial
cryostat
mm
thick
piec
absolut
aceton
min
tissu
section
incub
turkey
antisera
tcv
dilut
dilut
buffer
contain
mm
phosphat
buffer
nacl
bsa
humidifi
chamber
room
temperatur
min
wash
three
time
pb
buffer
intestin
section
incub
uorescein
isothiocyan
fitc
conjug
goat
antiturkey
igg
h
l
antibodi
kirkegaard
perri
laboratori
gaithersburg
md
dilut
dilut
buffer
room
temperatur
min
slide
coverslip
examin
microscop
nikon
tokyo
japan
ifa
stain
posit
tcv
antigen
appear
cytoplasm
enterocyt
intens
ifa
stain
score
scale
intens
stain
distribut
area
posit
stain
within
section
categor
diffus
multifoc
focal
score
respect
score
intens
area
distribut
ad
valu
indic
overal
amount
stain
section
higher
valu
indic
posit
stain
consist
ifa
assur
inclus
posit
control
intestin
section
turkey
embryo
infect
tcv
neg
control
intestin
section
normal
turkey
embryo
assay
calcul
mean
group
compar
oneway
analysi
varianc
anova
pool
ttest
use
determin
differ
p
p
effect
treatment
csa
cy
antibodi
respons
srbc
lymphocyt
prolifer
respons
whole
blood
cell
con
turkey
poult
prior
infect
tcv
shown
tabl
turkey
treat
cy
lower
p
antibodi
respons
srbc
untreat
control
trial
differ
antibodi
respons
srbc
turkey
treat
csa
untreat
control
statist
trial
consider
variat
lymphocyt
prolifer
respons
nevertheless
lymphocyt
prolifer
respons
turkey
treat
csa
lower
p
untreat
control
trial
lymphocyt
prolifer
respons
turkey
treat
cy
lower
p
untreat
control
trial
trial
effect
csaor
cyinduc
immunosuppress
bodi
weight
gain
turkey
experiment
infect
tcv
shown
tabl
bodi
weight
gain
treat
untreat
group
decreas
p
infect
tcv
compar
turkey
neither
treat
immunosuppress
infect
tcv
bodi
weight
gain
turkey
treat
cy
lower
p
untreat
control
experiment
infect
tcv
trial
differ
bodi
weight
gain
experiment
infect
tcv
turkey
treat
csa
untreat
control
statist
trial
effect
csaor
cyinduc
immunosuppress
sever
tcv
infect
intestin
turkey
poult
shown
tabl
h
pi
score
ifa
stain
tcv
antigen
infect
group
differ
among
group
treat
untreat
immunosuppress
day
pi
score
ifa
stain
tcv
antigen
infect
group
differ
among
group
treat
untreat
immunosuppress
trial
trial
day
pi
turkey
treat
cy
higher
p
score
ifa
stain
tcv
antigen
untreat
turkey
differ
score
turkey
treat
csa
untreat
control
statist
noninfect
control
turkey
remain
neg
tcv
antigen
intestin
ifa
throughout
entir
experiment
period
csa
select
cell
immunosuppress
activ
cell
mitogen
mix
lymphocyt
reaction
inhibit
csa
compound
exert
tabl
effect
csa
cy
humor
cellular
immun
respons
turkey
differ
group
treat
csa
cy
untreat
group
p
differ
group
treat
csa
cy
untreat
group
p
effect
act
prodrug
becom
activ
complex
endogen
intracellular
receptor
result
complex
block
late
stage
signal
pathway
initi
cell
receptor
block
effect
lead
failur
transcript
activ
cell
gene
encod
cytokin
particularli
interleukin
consequ
cellular
immun
respons
driven
expect
treatment
turkey
csa
caus
lymphocyt
prolifer
respons
con
limit
effect
antibodi
respons
srbc
effect
treatment
csa
infect
turkey
poult
tcv
could
determin
present
studi
howev
result
could
rule
involv
cellular
immun
tcv
infect
cell
function
complet
inhibit
csa
reveal
consider
lymphocyt
prolifer
respons
con
treatment
possibl
protect
effect
provid
cell
affect
partial
inhibit
effect
partial
inhibit
cell
function
csa
infect
turkey
poult
tcv
detect
evalu
method
present
studi
consider
variat
lymphocyt
prolifer
respons
individu
bird
may
caus
variat
number
lymphocyt
blood
sampl
time
sampl
collect
differ
bird
result
genet
divers
abil
chicken
lymphocyt
respond
con
genet
control
lymphocyt
chicken
genet
differ
differ
prolif
respons
con
addit
genet
select
turkey
increas
bodi
weight
egg
product
affect
mitogen
respons
turkey
lymphocyt
con
turkey
present
studi
obtain
commerci
origin
outbr
breeder
stock
divers
genet
background
similar
tabl
effect
csa
cy
bodi
weight
gain
turkey
poult
experiment
infect
tcv
mechan
genet
control
demonstr
chicken
lymphocyt
may
also
contribut
observ
individu
variat
lymphocyt
prolifer
respons
turkey
comparison
cellular
immun
avian
ibv
demonstr
prolifer
lymphocyt
delayedtyp
hypersensit
increas
popul
cell
experiment
suppress
chicken
cell
csa
enhanc
viru
titer
kidney
spleen
mononuclear
cell
chicken
vaccin
live
ibv
show
lymphocyt
prolifer
produc
interferong
respons
vitro
stimul
homolog
heterolog
strain
ibv
cytotox
lymphocyt
ctl
respons
ibv
demonstr
correl
initi
decreas
amount
viru
kidney
lung
clinic
respiratori
sign
ill
adopt
transfer
lymphocyt
chick
infect
ibv
protect
chick
challeng
infect
function
ctl
epitop
probabl
present
spike
nucleocapsid
structur
protein
ibv
treatment
newli
hatch
turkey
poult
cy
alkyl
agent
shown
caus
antibodi
respons
srbc
persist
cellular
degener
bursa
bursadepend
area
major
lymphoid
organ
result
present
studi
reveal
decreas
antibodi
respons
srbc
turkey
tabl
effect
csa
cy
sever
tcv
infect
determin
stain
intens
distribut
tcv
intestin
turkey
poult
experiment
infect
tcv
turkey
poult
infect
tcv
day
old
frozen
turkey
intestin
section
incub
turkey
antiserum
tcv
subsequ
incub
isothiocyan
fitc
conjug
goat
antiturkey
igg
h
l
antibodi
noninfect
control
turkey
intestin
neg
tcv
ifa
throughout
entir
experiment
period
data
shown
differ
group
treat
cy
untreat
group
p
intens
ifa
stain
score
scale
intens
stain
distribut
area
posit
stain
within
section
categor
diffus
multifoc
focal
score
respect
score
intens
area
distribut
ad
data
express
meansd
score
ifa
stain
turkey
poult
group
higher
valu
indic
intens
stain
c
nd
done
turkey
poult
treat
csa
mg
per
kg
bodi
weight
day
old
trial
day
old
trial
everi
third
day
thereaft
e
turkey
poult
treat
cy
mg
per
turkey
poult
per
day
day
posthatch
poult
treat
cy
data
suggest
b
cell
major
target
cy
turkey
poult
undetect
antibodi
respons
turkey
poult
treat
cy
srbc
trial
caus
reagent
oper
problem
sampl
differ
group
treat
examin
way
simultan
also
necessarili
complet
elimin
humor
b
cell
activ
antibodi
respons
srbc
may
detect
evalu
method
hemagglutin
assay
nevertheless
treatment
cy
present
studi
suppress
humor
b
cell
activ
subsequ
enhanc
sever
tcv
infect
turkey
poult
reveal
markedli
decreas
bodi
weight
gain
higher
score
ifa
stain
tcv
antigen
intestin
humor
antibodi
respons
avian
ibv
chicken
measur
enzymelink
immunosorb
assay
hemagglutinationinhibit
test
viru
neutral
test
vaccin
studi
ibv
gener
correl
humor
antibodi
respons
protect
protect
role
b
cell
ibv
infect
shown
select
experiment
suppress
chemic
cy
hormon
testosteron
propion
surgic
bursectomi
chicken
treat
cy
longer
persist
ibv
subsequ
show
increas
clinic
sign
sever
histopatholog
lesion
kidney
high
titer
humor
antibodi
correl
absenc
viru
recoveri
kidney
genit
tract
seem
protect
tracheal
epithelium
challeng
infect
spike
protein
ibv
consid
major
structur
protein
induc
protect
humor
antibodi
respons
antibodi
gener
mice
use
recombin
spike
protein
inoculum
could
neutral
ibv
infect
ciliostasi
test
tracheal
organ
cultur
immun
recombin
fragment
spike
glycoprotein
protect
chicken
challeng
infect
ibv
decreas
bodi
weight
gain
one
major
characterist
turkey
coronavir
enter
infect
tcv
caus
rapid
histopatholog
chang
mucosa
intestin
tract
turkey
poult
ultrastructur
chang
includ
granular
epitheli
cell
loss
microvilli
margin
chromatin
nucleu
increas
cellular
lamina
propria
alter
intestin
tract
caus
failur
absorpt
accumul
gase
result
diarrhea
decreas
bodi
weight
gain
bodi
weight
gain
turkey
poult
treat
csa
cy
without
treatment
csa
cy
decreas
infect
tcv
compar
noninfect
control
treatment
cy
increas
sever
tcv
infect
turkey
poult
bodi
weight
gain
turkey
treat
cy
lower
turkey
treat
csa
cy
infect
tcv
consider
lymphocyt
prolifer
respons
detect
turkey
poult
treat
csa
trial
initi
treatment
csa
turkey
poult
group
begin
day
old
trial
chang
day
old
trial
order
enhanc
suppress
effect
cellular
immun
turkey
poult
day
old
infect
tcv
detect
tcv
intestin
ifa
time
point
h
pi
trial
repeat
trial
differ
amount
stain
group
interv
observ
trial
differ
amount
stain
group
h
pi
expect
trial
suggest
similar
amount
stain
among
group
day
pi
trial
contrast
time
point
day
pi
trial
chang
day
pi
order
examin
greater
differ
group
treat
csa
cy
group
treat
csa
cy
level
tcv
antigen
high
intestin
turkey
poult
within
week
follow
infect
level
tcv
antigen
declin
day
pi
antibodi
respons
rose
markedli
loa
et
al
unpublish
data
suggest
protect
role
humor
immun
tcv
infect
turkey
poult
consist
observ
result
present
studi
also
reveal
declin
tcv
antigen
intestin
turkey
poult
treat
csa
cy
day
pi
addit
present
studi
show
suppress
humor
immun
cy
enhanc
sever
tcv
infect
intestin
turkey
poult
infect
tcv
summari
decreas
bodi
weight
gain
along
increas
sever
tcv
infect
turkey
poult
treat
cy
infect
tcv
suggest
humor
immun
may
provid
protect
immun
turkey
poult
infect
tcv
